Fig. 3From: Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s diseaseNeurofilament light chain (NfL) plasma levels plotted against age in nondemented controls (green) and the AD patients (a combined group of MCI-AD and ADD subjects, red). The black dotted line represents the optimal separation of the two groups according to Fisher’s LDABack to article page